Prevalence and Symptom Profile of Long COVID among Schoolchildren in Vietnam
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design and Setting
2.2. Procedure and Measurement
2.3. Independent Variables
2.4. Outcome Variables
2.4.1. Long COVID
2.4.2. The EQ-5D-Y Questionnaire
2.5. Data Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Over 19 Percent of Children in Vietnam Contract COVID-19. Available online: https://en.vietnamplus.vn/over-19-percent-of-children-in-vietnam-contract-covid-19-post222215.vnp (accessed on 30 July 2023).
- Information Portal of Thai Nguyen on the COVID-19 PANDEMIC [Internet]. 2023. Available online: http://covid.thainguyen.gov.vn/ (accessed on 30 July 2023).
- An, M. Thai Nguyen Province Is Implementing COVID-19 Vaccination for Children Aged 12–17. Thai Nguyen Center for Disease Control. Available online: http://covid.thainguyen.gov.vn/ContentDetail/NewsDetailView?NewsId=d234d5a9-923c-4135-aac6-c2c831c13c25 (accessed on 30 July 2023).
- Station Tnrat. [Infographic] Thai Nguyen Leads the Country in the Vaccination Rate against COVID-19. 2022. Available online: https://thainguyentv.vn/infographic-thai-nguyen-dung-dau-ca-nuoc-ve-ty-le-tiem-vaccine-phong-covid-19-88289.html (accessed on 30 July 2023).
- World Health Organization. Post COVID-19 Condition (Long COVID); World Health Organization Europe: Geneva, Switzerland, 2022; Available online: https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition (accessed on 30 July 2023).
- Lopez-Leon, S.; Wegman-Ostrosky, T.; del Valle, N.C.A.; Perelman, C.; Sepulveda, R.; Rebolledo, P.A.; Cuapio, A.; Villapol, S. Long-COVID in children and adolescents: A systematic review and meta-analyses. Sci Rep. 2022, 12, 9950. [Google Scholar] [CrossRef] [PubMed]
- Osmanov, I.M.; Spiridonova, E.; Bobkova, P.; Gamirova, A.; Shikhaleva, A.; Andreeva, M.; Blyuss, O.; El-Taravi, Y.; DunnGalvin, A.; Comberiati, P.; et al. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study. Eur Respir J. 2022, 59, 2101341. [Google Scholar] [CrossRef] [PubMed]
- Stephenson, T.; Pinto Pereira, S.M.; Shafran, R.; de Stavola, B.L.; Rojas, N.; McOwat, K.; Simmons, R.; Zavala, M.; O’Mahoney, L.; Chalder, T.; et al. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): A national matched cohort study. Lancet Child Adolesc. Health 2022, 6, 230–239. [Google Scholar] [CrossRef] [PubMed]
- O’Mahoney, L.L.; Routen, A.; Gillies, C.; Ekezie, W.; Welford, A.; Zhang, A.; Karamchandani, U.; Simms-Williams, N.; Cassambai, S.; Ardavani, A.; et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. eClinicalMedicine 2023, 55, 101762. [Google Scholar] [CrossRef] [PubMed]
- European Foundation. EQ-5D-5L—EQ-5D—EuroQol. Available online: https://euroqol.org/eq-5d-instruments/eq-5d-5l-about/ (accessed on 29 September 2023).
- Mai, V.Q.; Sun, S.; Van Minh, H.; Luo, N.; Giang, K.B.; Lindholm, L.; Sahlen, K.G. An EQ-5D-5L Value Set for Vietnam. Qual. Life Res. 2020, 29, 1923–1933. [Google Scholar] [CrossRef]
- Nguyen, L.H.; Tran, B.X.; Hoang Le, Q.N.; Tran, T.T.; Latkin, C.A. Quality of life profile of general Vietnamese population using EQ-5D-5L. Health Qual. Life Outcomes 2017, 15, 199. [Google Scholar] [CrossRef] [PubMed]
- Wille, N.; Badia, X.; Bonsel, G.; Burström, K.; Cavrini, G.; Devlin, N.; Egmar, A.-C.; Greiner, W.; Gusi, N.; Herdman, M.; et al. Development of the EQ-5D-Y: A child-friendly version of the EQ-5D. Qual. Life Res. 2010, 19, 875–886. [Google Scholar] [CrossRef] [PubMed]
- Borch, L.; Holm, M.; Knudsen, M.; Ellermann-Eriksen, S.; Hagstroem, S. Long COVID symptoms and duration in SARS-CoV-2 positive children—A nationwide cohort study. Eur. J. Pediatr. 2022, 181, 1597–1607. [Google Scholar] [CrossRef] [PubMed]
- Donnachie, E.; Hapfelmeier, A.; Linde, K.; Tauscher, M.; Gerlach, R.; Greissel, A.; Schneider, A. Incidence of post-COVID syndrome and associated symptoms in outpatient care in Bavaria, Germany: A retrospective cohort study using routinely collected claims data. BMJ Open 2022, 12, e064979. [Google Scholar] [CrossRef]
- Pinto Pereira, S.M.; Nugawela, M.D.; McOwat, K.; Dalrymple, E.; Xu, L.; Ladhani, S.N.; Simmons, R.; Chalder, T.; Swann, O.; Ford, T.; et al. Symptom Profiles of Children and Young People 12 Months after SARS-CoV-2 Testing: A National Matched Cohort Study (The CLoCk Study). Children 2023, 10, 1227. [Google Scholar] [CrossRef] [PubMed]
- Kikkenborg Berg, S.; Palm, P.; Nygaard, U.; Bundgaard, H.; Petersen, M.N.S.; Rosenkilde, S.; Thorsted, A.B.; Ersbøll, A.K.; Thygesen, L.C.; Nielsen, S.D.; et al. Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched controls in Denmark (LongCOVIDKidsDK): A national, cross-sectional study. Lancet Child Adolesc. Health 2022, 6, 614–623. [Google Scholar] [CrossRef] [PubMed]
- Pinto Pereira, S.M.; Shafran, R.; Nugawela, M.D.; Panagi, L.; Hargreaves, D.; Ladhani, S.N.; Bennett, S.D.; Chalder, T.; Dalrymple, E.; Ford, T.; et al. Natural course of health and well-being in non-hospitalised children and young people after testing for SARS-CoV-2: A prospective follow-up study over 12 months. Lancet Reg. Health Eur. 2023, 25, 100554. [Google Scholar] [CrossRef] [PubMed]
- Say, D.; Crawford, N.; McNab, S.; Wurzel, D.; Steer, A.; Tosif, S. Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. Lancet Child Adolesc. Health 2021, 5, e22–e23. [Google Scholar] [CrossRef] [PubMed]
- Ludvigsson, J.F. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Paediatr. 2021, 110, 914–921. [Google Scholar] [CrossRef] [PubMed]
- Molteni, E.; Sudre, C.H.; Canas, L.S.; Bhopal, S.S.; Hughes, R.C.; Antonelli, M.; Murray, B.; Kläser, K.; Kerfoot, E.; Chen, L.; et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc. Health 2021, 5, 708–718. [Google Scholar] [CrossRef] [PubMed]
- Miller, F.; Nguyen, V.; Navaratnam, A.M.; Shrotri, M.; Kovar, J.; Hayward, A.C.; Fragaszy, E.; Aldridge, R.W.; Hardelid, P.; on behalf of the VirusWatch Collaborative. Prevalence and Characteristics of Persistent Symptoms in Children During the COVID-19 Pandemic: Evidence from a Household Cohort Study in England and Wales. Pediatr. Infect. Dis. J. 2022, 41, 979–984. [Google Scholar] [CrossRef] [PubMed]
- Sterky, E.; Olsson-Åkefeldt, S.; Hertting, O.; Herlenius, E.; Alfven, T.; Rinder, M.R.; Rhedin, S.; Hildenwall, H. Persistent symptoms in Swedish children after hospitalisation due to COVID-19. Acta Paediatr. 2021, 110, 2578–2580. [Google Scholar] [CrossRef] [PubMed]
- Ashkenazi-Hoffnung, L.; Shmueli, E.; Ehrlich, S.; Ziv, A.; Bar-On, O.; Birk, E.; Lowenthal, A.; Prais, D. Long COVID in Children: Observations from a Designated Pediatric Clinic. Pediatr. Infect. Dis. J. 2021, 40, e509–e511. [Google Scholar] [CrossRef]
- Brackel, C.L.H.; Lap, C.R.; Buddingh, E.P.; van Houten, M.A.; van der Sande, L.; Langereis, E.J.; Bannier, M.A.G.E.; Pijnenburg, M.W.H.; Hashimoto, S.; Terheggen-Lagro, S.W.J.; et al. Pediatric long-COVID: An overlooked phenomenon? Pediatr. Pulmonol. 2021, 56, 2495–2502. [Google Scholar] [CrossRef]
- Allgaier, A.K.; Pietsch, K.; Frühe, B.; Prast, E.; Sigl-Glöckner, J.; Schulte-Körne, G. Depression in pediatric care: Is the WHO-Five Well-Being Index a valid screening instrument for children and adolescents? Gen. Hosp. Psychiatry 2012, 34, 234–241. [Google Scholar] [CrossRef]
Without Prior SARS-CoV-2 Infection # (N = 686) | With Prior SARS-CoV-2 Infection * (N = 1540) | |
---|---|---|
Sex | ||
Male | 354 (51.6%) | 737 (47.9%) |
Female | 332 (48.4%) | 803 (52.1%) |
Age | ||
11 | 40 (5.8%) | 202 (13.1%) |
12 | 43 (6.3%) | 223 (14.5%) |
13 | 72 (10.5%) | 213 (13.8%) |
14 | 51 (7.4%) | 258 (16.8%) |
15 | 131 (19.1%) | 247 (16.0%) |
16 | 180 (26.2%) | 207 (13.4%) |
17 | 169 (24.6%) | 190 (12.3%) |
Schooling | ||
Secondary school | 221 (32.2%) | 968 (62.9%) |
High school | 465 (67.8%) | 572 (37.1%) |
Previous COVID-19 vaccination | ||
No | 32 (4.7%) | 70 (4.5%) |
Yes | 620 (90.4%) | 1455 (94.5%) |
Don’t know | 34 (5.0%) | 15 (1.0%) |
Number of COVID-19 vaccine doses received | ||
0 | 32 (4.7%) | 70 (4.5%) |
1 | 9 (1.3%) | 107 (6.9%) |
2 | 132 (19.2%) | 449 (29.2%) |
3 | 414 (60.3%) | 836 (54.3%) |
4 | 24 (3.5%) | 39 (2.5%) |
missing | 75 (10.9%) | 39 (2.5%) |
Type of COVID-19 vaccine received | ||
None | 32 (4.7%) | 70 (4.5%) |
Pfizer | 466 (67.9%) | 1186 (77.0%) |
Moderna | 57 (8.3%) | 125 (8.1%) |
Other | 5 (0.7%) | 10 (0.6%) |
Do not know | 95 (13.8%) | 135 (8.8%) |
Missing | 31 (4.5%) | 14 (0.9%) |
Underlying/chronic medical conditions | ||
No | 610 (88.9%) | 1421 (92.3%) |
Yes | 12 (1.7%) | 52 (3.4%) |
Don’t know | 64 (9.3%) | 67 (4.4%) |
Children with Long COVID 1 | ||
No | NA | 1422 (94.4%) |
Yes | NA | 85 (5.6%) |
Children with at least one acute symptom 2 | ||
No | 512 (74.6%) | 298 (19.4%) |
Yes | 174 (25.4%) | 1242 (80.6%) |
Children without Prior SARS-CoV-2 Infection 1 but at Least One Acute Symptom * (N = 174) | Children with Prior SARS-CoV-2 Infection 2 and at Least One Acute Symptom * (N = 1242) | Children with at Least one Long COVID # Symptom (N = 85) | |
---|---|---|---|
Your child’s studying has been affected by any of the symptoms | |||
Strongly disagree | 4 (2.3%) | 50 (4.0%) | 9 (11%) |
Somewhat disagree | 42 (24.1%) | 242 (19.5%) | 6 (7%) |
Neither disagree nor agree | 28 (16.1%) | 199 (16.0%) | 12 (14%) |
Somewhat agree | 48 (27.6%) | 343 (27.6%) | 39 (46%) |
Strongly agree | 16 (9.2%) | 193 (15.5%) | 14 (16%) |
Do not know | 36 (20.7%) | 215 (17.3%) | 5 (6%) |
Missing | 0 (0.0%) | 0 (0.0%) | |
Your child has been able to continue his/her usual daily activities? | |||
Yes, my child was able to fully return to usual activities of daily life within a month of his/her COVID illness | NA | 960 (77.3%) | 54 (64%) |
Yes, but my child needed more than a month before he/she was able to fully return to usual activities of daily life | NA | 157 (12.6%) | 12 (14%) |
Yes, but my child had to increase rest hours of his/her usual daily life activities | NA | 68 (5.5%) | 15 (18%) |
No, my child had to stop one or many activities of his/her daily life activities | NA | 16 (1.3%) | 0 (0.0%) |
Do not know | NA | 41 (3.3%) | 4 (5%) |
Missing | NA | 0 (0.0%) | 0 (0.0%) |
As of today, do you think your child has fully recovered from COVID-19 | |||
Strongly disagree | NA | 90 (7.2%) | 5 (6%) |
Somewhat disagree | NA | 121 (9.7%) | 15 (18%) |
Neither disagree nor agree | NA | 145 (11.7%) | 17 (20%) |
Somewhat agree | NA | 288 (23.2%) | 23 (27%) |
Strongly agree | NA | 313 (25.2%) | 14 (16%) |
Do not know | NA | 285 (22.9%) | 11 (13%) |
Children without Prior SARS-CoV-2 Infection 1 but at Least One Acute Symptom * (N = 174) | Children with Prior SARS-CoV-2 Infection 2 and at Least One Acute Symptom * (N = 1242) | Children with Long COVID # (N = 85) | |
---|---|---|---|
Saw a doctor or visited a commune health center/hospital because of any clinical symptoms | |||
No | 137 (78.7%) | 1080 (87.0%) | 70 (82%) |
Yes | 19 (10.9%) | 138 (11.1%) | 13 (15%) |
Do not know | 18 (10.3%) | 24 (1.9%) | 2 (2%) |
Missing | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
Attended an emergency department because of any of the clinical symptoms | |||
No | 154 (88.5%) | 1202 (96.8%) | 79 (93%) |
Yes | 4 (2.3%) | 20 (1.6%) | 4 (5%) |
Do not know | 16 (9.2%) | 20 (1.6%) | 2 (2%) |
Missing | 0 (0.0%) | 0 (0.0%) | |
Admitted to a hospital because of any of the clinical symptoms | |||
No | 152 (87.4%) | 1193 (96.1%) | 77 (91%) |
Yes | 4 (2.3%) | 33 (2.7%) | 7 (8%) |
Do not know | 18 (10.3%) | 16 (1.3%) | 1 (1%) |
Missing | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
Had to stay at home from school because of any of the clinical symptoms | |||
No | 125 (71.8%) | 857 (69.0%) | 52 (61%) |
Yes | 34 (19.5%) | 365 (29.4%) | 31 (36%) |
Do not know | 15 (8.6%) | 20 (1.6%) | 2 (2%) |
Missing | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
Children without Prior SARS-CoV-2 Infection 1 (N = 686): Status at Time of Survey (N = 686) | Children with Prior SARS-CoV-2 Infection 2 (N = 1540) | ||
---|---|---|---|
EQ-5D-Y Dimension | Status before Their Infection | Status at Time of Survey | |
Mobility | |||
No problems | 677 (98.7%) | 1521 (98.8%) | 1527 (99.2%) |
Some problems | 5 (0.7%) | 18 (1.2%) | 12 (0.8%) |
A lot of problems | 4 (0.6%) | 1 (0.1%) | 1 (0.1%) |
Looking After Myself | |||
No problems | 677 (98.7%) | 1519 (98.6%) | 1531 (99.4%) |
Some problems | 2 (0.3%) | 14 (0.9%) | 7 (0.5%) |
A lot of problems | 7 (1.0%) | 7 (0.5%) | 2 (0.1%) |
Doing Usual Activities | |||
No problems | 680 (99.1%) | 1505 (97.7%) | 1518 (98.6%) |
Some problems | 4 (0.6%) | 31 (2.0%) | 20 (1.3%) |
A lot of problems | 2 (0.3%) | 4 (0.3%) | 2 (0.1%) |
Having Pain or Discomfort | |||
No problems | 678 (98.8%) | 1423 (92.4%) | 1476 (95.8%) |
Some problems | 6 (0.9%) | 111 (7.2%) | 60 (3.9%) |
A lot of problems | 2 (0.3%) | 6 (0.4%) | 4 (0.3%) |
Feeling Worried, Sad, or Unhappy | |||
No problems | 661 (96.4%) | 1394 (90.5%) | 1434 (93.1%) |
Some problems | 20 (2.9%) | 137 (8.9%) | 98 (6.4%) |
A lot of problems | 5 (0.7%) | 9 (0.6%) | 8 (0.5%) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Vu, T.T.; Nguyen, K.C.; Nguyen, H.T.; Hoang, A.; Ngu, N.D.; Tran, D.N.; Phan, H.B.; Nguyen, H.T.T.; Pham, T.Q.; Vogt, F. Prevalence and Symptom Profile of Long COVID among Schoolchildren in Vietnam. Viruses 2024, 16, 1021. https://doi.org/10.3390/v16071021
Vu TT, Nguyen KC, Nguyen HT, Hoang A, Ngu ND, Tran DN, Phan HB, Nguyen HTT, Pham TQ, Vogt F. Prevalence and Symptom Profile of Long COVID among Schoolchildren in Vietnam. Viruses. 2024; 16(7):1021. https://doi.org/10.3390/v16071021
Chicago/Turabian StyleVu, Trang Thu, Khanh Cong Nguyen, Hieu Thi Nguyen, Anh Hoang, Nghia Duy Ngu, Duong Nhu Tran, Hoa Bich Phan, Ha Thi Thu Nguyen, Thai Quang Pham, and Florian Vogt. 2024. "Prevalence and Symptom Profile of Long COVID among Schoolchildren in Vietnam" Viruses 16, no. 7: 1021. https://doi.org/10.3390/v16071021
APA StyleVu, T. T., Nguyen, K. C., Nguyen, H. T., Hoang, A., Ngu, N. D., Tran, D. N., Phan, H. B., Nguyen, H. T. T., Pham, T. Q., & Vogt, F. (2024). Prevalence and Symptom Profile of Long COVID among Schoolchildren in Vietnam. Viruses, 16(7), 1021. https://doi.org/10.3390/v16071021